We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HYNE:NASDAQHoyne Bancorp, Inc. Analysis

Data as of 2026-05-23 - not real-time

$15.82

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Hoyne Bancorp is trading at $15.82, comfortably above its 20‑day ($15.67), 50‑day ($15.35) and 200‑day ($14.72) simple moving averages, indicating a short‑term bullish bias. The RSI of 60.6 suggests momentum is still intact but approaching overbought territory, while the MACD histogram is negative and the signal line is bearish, hinting at a possible near‑term tops. The stock sits on a support level around $15.49 and faces resistance near $16.00, with stable volume supporting the price action. Valuation metrics are mixed: a trailing P/E of 395.5 far exceeds the industry average of 16.8, flagging severe overvaluation on earnings, yet the price‑to‑book of 0.79 is below 1.0, implying a discount to net asset value. Revenue growth of 12.9% is respectable for a regional bank, but operating margins are negative (-2.96%) and profit margin is modest (1.76%), reflecting thin profitability. The balance sheet is strong, with $14.36 M in cash versus $1.42 M in debt and a debt‑to‑equity ratio effectively zero, providing ample liquidity. However, operating cash flow is negative and free cash flow is zero, raising concerns about cash generation sustainability. Volatility over the past 30 days sits at 13.1% and beta is low at 0.25, indicating limited market‑wide price swings. The sector faces heightened credit and interest‑rate risk, and regulatory oversight remains a constant factor for banks. Recent Barron’s coverage provides a neutral sentiment backdrop without altering the fundamental outlook.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price approaching resistance near $16.00
  • Bearish MACD signal
  • Extremely high P/E relative to peers

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of 12.9% supporting top‑line expansion
  • Strong cash position versus minimal debt
  • Mixed valuation signals (low P/B but high P/E)

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Price‑to‑book below 1 indicating asset‑value discount
  • Low beta and modest volatility suggesting defensive profile
  • Potential for consolidation in the regional banking sector

Key Metrics & Analysis

Financial Health

Revenue Growth12.90%
Profit Margin1.76%
P/E Ratio395.5
ROE0.22%
ROA0.06%
P/B Ratio0.8
Op. Cash Flow$-481449
Industry P/E16.8

Technical Analysis

TrendBullish
RSI60.6
Support$15.49
Resistance$16.00
MA 20$15.67
MA 50$15.35
MA 200$14.72
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta0.25
Volatility13.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.